4 doctors weighed in:
Are there any promising trials for new ulcerative colitis treatments?
4 doctors weighed in

Dr. Michael Fisher
Dermatology
3 doctors agree
In brief: Trials for colitis
An open-label study of vedolizumab (mln0002) in patients with ulcerative colitis and crohn's disease this multicenter, 2-year open-label study will collect data on the occurrence of important clinical safety events resulting from chronic vedolizumab (mln0002) administration.

In brief: Trials for colitis
An open-label study of vedolizumab (mln0002) in patients with ulcerative colitis and crohn's disease this multicenter, 2-year open-label study will collect data on the occurrence of important clinical safety events resulting from chronic vedolizumab (mln0002) administration.
Dr. Michael Fisher
Dr. Michael Fisher
Thank
Dr. Michael Fisher
Dermatology
1 doctor agrees
In brief: Trials for colitis
An open-label study of vedolizumab (mln0002) in patients with ulcerative colitis and crohn's disease this multicenter, 2-year open-label study will collect data on the occurrence of important clinical safety events resulting from chronic vedolizumab (mln0002) administration.

In brief: Trials for colitis
An open-label study of vedolizumab (mln0002) in patients with ulcerative colitis and crohn's disease this multicenter, 2-year open-label study will collect data on the occurrence of important clinical safety events resulting from chronic vedolizumab (mln0002) administration.
Dr. Michael Fisher
Dr. Michael Fisher
Thank
Get help from a real doctor now
Dr. Crystal Twynham
Board Certified, Surgery
29 years in practice
938K people helped
Continue
108,000 doctors available
Read more answers from doctors